A group of advisers for the CDC voted to narrow existing recommendations for the combined MMRV shot that protects against ...

The CDC's vaccine safety advisory board postponed a controversial decision to no longer recommend a newborn Hepatitis B vaccine.

The Trump administration is continuing its push to revise federal guidelines to delay the hepatitis B vaccine newborn dose for most children.

At the meeting on Thursday, CDC staffers summarized the results of 17 studies, which found that the hepatitis B vaccine is ...

The group was chosen by Health Secretary Robert F. Kennedy Jr. amid controversy. It's changed guidance for for measles, mumps ...

Dr. Nancy Reau of Rush University Medical Center explains the CDC’s new recommendations that all infants, most adults under ...

A key vaccine advisory panel at the Centers for Disease Control and Prevention voted to change its recommendations around ...

Key vaccine advisers to the Centers for Disease Control and Prevention voted 11-1 Friday morning to delay a recommendation on ...

The Advisory Committee on Immunization Practices, called ACIP, was expected on Friday to vote on the at-birth hepatitis B vaccine and on COVID-19.

Hepatitis B infections plummeted after the CDC began recommending a universal dose of the vaccine at birth in 1991. (gorodenkoff / Getty Images) The hepatitis B vaccine has emerged as the latest ...

Before the vaccine, there were 18,000 annual infant infections; now, there are about 20 reported cases per year.